• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 29, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Intrinsic Capacity Heavily Impaired in Nigerians Ageing with HIV

by
October 29, 2026
in Health
Reading Time: 3 mins read
0
Intrinsic Capacity Heavily Impaired in Nigerians Ageing with HIV

Intrinsic Capacity Heavily Impaired in Nigerians Ageing with HIV

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

People living with HIV who receive antiretroviral therapy at a clinic in Plateau State, Nigeria, show markedly reduced intrinsic capacity compared with HIV-negative peers, according to a cross-sectional study published in AIDS Research and Therapy.

The research team, led by Oluseye Ajayi with colleagues including Prosper Okonkwo, assessed 239 age-matched people living with HIV on antiretroviral therapy and 234 people living without HIV attending the same clinic setting. Screening relied on the WHO nine-item ICOPE brief screening tool, which flags signs of loss across the individual capacity domains. Any participant showing a sign of loss in one or more domain items was classified as having impaired intrinsic capacity.

The headline result was stark. Overall composite impaired intrinsic capacity was recorded in 217 of the participants living with HIV, or 98.0 percent, against 109 of those living without HIV, or 46.6 percent, a difference the authors characterise as roughly elevenfold and statistically significant. The groups were not identical at baseline: the mean age was 41.4 years among people living with HIV versus 38.5 years among the comparison group, and 77.8 percent of the HIV group were women compared with 65.0 percent of the comparison group, differences that reached statistical significance.

Across the separate capacity domains, impairment was three to four times more common among people living with HIV than among those without the virus, with the notable exception of the mobility domain, where the gap was not observed.

Using univariate and multivariate logistic regression at a 0.05 significance level, the researchers identified three factors associated with intrinsic capacity in the HIV group after adjusting for confounders: current age, duration on antiretroviral therapy and CD4 count. The association with treatment duration is intriguing but, given the cross-sectional design, cannot establish whether longer exposure to therapy, longer time living with the virus, or unmeasured disease history drives the signal.

The authors frame the findings as evidence that HIV may compromise the biological systems underpinning intrinsic capacity, potentially accelerating ageing and raising vulnerability to adverse health outcomes among people living with HIV. They argue that ageing assessments in this population should adopt a functional approach rather than a disease-based one, so that declines in capacity are detected early and functional ability is preserved.

Several caveats deserve emphasis. The study is cross-sectional and analytical, so it captures associations at a single point in time and cannot demonstrate that HIV causes capacity decline over a person’s lifetime. The sample comes from a single clinic in Plateau State, and the age and sex composition of the two groups differed, factors the statistical adjustments may only partly address. The ICOPE tool is a brief screening instrument, so an impaired classification indicates flagged concerns that would typically warrant fuller clinical evaluation rather than confirmed diagnoses.

The article was published as open access on 10 October 2026 and, at the time of this report, is being shared as an early peer-reviewed accepted version that remains citable and carries a permanent DOI ahead of the final version of record.

Subject of Research: Intrinsic capacity impairment and its associated factors among people ageing with HIV in Nigeria

Article Title: Intrinsic capacity and associated factors in people ageing with human immunodeficiency virus in Nigeria

Article References: Ajayi, O., Ajayi, O., Adetoye, D., & Okonkwo, P. (2026). Intrinsic capacity and associated factors in people ageing with human immunodeficiency virus in Nigeria. AIDS Research and Therapy. https://doi.org/10.1186/s12981-026-00955-5

Image Credits: AI Generated

DOI: 10.1186/s12981-026-00955-5

Keywords: HIV, intrinsic capacity, ageing, Nigeria, antiretroviral therapy, ICOPE screening tool, cross-sectional study, CD4 count, functional ability, WHO, Intrinsic, capacity

News Source: Beatrice Stafford. (October 29, 2026). Intrinsic Capacity Heavily Impaired in Nigerians Ageing with HIV. Scienmag.

Tags: ageingantiretroviral therapycapacityCD4 countCross-sectional Studyfunctional abilityHivICOPE screening toolIntrinsicIntrinsic capacityNigeriaWHO
Share12Tweet7Share2ShareShareShare1

Related Posts

Global Financing Facility falls short on adolescent health funding in three country case studies

Global Financing Facility falls short on adolescent health funding in three country case studies

October 29, 2026
Prostate Cancer Detection Rose After MRI Arrived, But a Single-Centre Study Says the Reason Stays Unclear

Prostate Cancer Detection Rose After MRI Arrived, But a Single-Centre Study Says the Reason Stays Unclear

October 29, 2026

Never-Smoker COPD Shows Stronger Lung Function Gains from Salbutamol and Glycopyrronium

October 29, 2026

Chlorhexidine adds no benefit to oral-care bundles for preventing ventilator-associated pneumonia

October 29, 2026

POPULAR NEWS

  • Global Financing Facility falls short on adolescent health funding in three country case studies

    Global Financing Facility falls short on adolescent health funding in three country case studies

    29 shares
    Share 12 Tweet 7
  • Prostate Cancer Detection Rose After MRI Arrived, But a Single-Centre Study Says the Reason Stays Unclear

    29 shares
    Share 12 Tweet 7
  • Midday Sunlight Yields Smaller Copper Nanoparticles With Stronger Antibacterial Activity

    29 shares
    Share 12 Tweet 7
  • Never-Smoker COPD Shows Stronger Lung Function Gains from Salbutamol and Glycopyrronium

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Global Financing Facility falls short on adolescent health funding in three country case studies

Prostate Cancer Detection Rose After MRI Arrived, But a Single-Centre Study Says the Reason Stays Unclear

Midday Sunlight Yields Smaller Copper Nanoparticles With Stronger Antibacterial Activity

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.